Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Martina Napolitano
Observed names:
M Napolitano,
M. Napolitano
Institution:
Azienda Ospedaliero-Universitaria di Modena
Observed institutions:
University of Modena and Reggio Emilia,
Marche Polytechnic University,
Azienda Ospedaliero-Universitaria delle Marche,
Azienda Ospedaliero-Universitaria di Modena,
Istituto di Chimica Biomolecolare,
National Research Council
show all 6
ORCID:
0000-0002-1130-446X
Observed ORCID:
0000-0002-1130-446X
OpenAlex ID:
A5032066133
Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives
2018
·
Chiara Tomasello
, Cinzia Baldessari
, et al.
·
Critical Reviews in Oncology/Hematology
·
69
NUT midline carcinoma of the head and neck: current perspectives
2019
·
Martina Napolitano
, Marta Venturelli
, et al.
·
OncoTargets and Therapy
·
68
PDF
Second primary tumors in head and neck cancer patients: The importance of a “tailored” surveillance
2020
·
Federica Bertolini
, Lucia Trudu
, et al.
·
Oral Diseases
·
37
Risk of Second Primary Malignancy in Breast Cancer Survivors: A Nested Population-Based Case-Control Study
2015
·
Raffaella Marcheselli
, Luigi Marcheselli
, et al.
·
Journal of Breast Cancer
·
34
PDF
Immunotherapy in head and neck cancer: The great challenge of patient selection
2019
·
Martina Napolitano
, Francesca Matilde Schipilliti
, et al.
·
Critical Reviews in Oncology/Hematology
·
24
The Prognostic Role of Baseline Eosinophils in HPV-Related Cancers: a Multi-institutional Analysis of Anal SCC and OPC Patients Treated with Radical CT-RT
2022
·
Margherita Rimini
, Pierfrancesco Franco
, et al.
·
Journal of Gastrointestinal Cancer
·
6
PDF
Exceptional response to lurbinectedin and irinotecan in BRCA -mutated platinum-resistant ovarian cancer patient: a case report
2022
·
Laura Cortesi
, Marta Venturelli
, et al.
·
Therapeutic Advances in Chronic Disease
·
5
Neratinib and the Role of Anti‐ HER2 Therapy in Salivary Duct Carcinoma
2025
·
Martina Napolitano
, Lucia Trudu
, et al.
·
Cancer Reports
·
4
PDF
Unexpected Response to Nivolumab in a “Fast Progressor” Head and Neck Cancer Patient
2019
·
Martina Napolitano
, Lucia Trudu
, et al.
·
Case Reports in Oncology
·
4
PDF
Other Than Complete Response in Oropharyngeal Carcinoma: Patient and Tumor‐Related Factors
2025
·
Francesco Mattioli
, Matteo Miglio
, et al.
·
Laryngoscope Investigative Otolaryngology
·
1
PDF
Real-world outcomes of immunotherapy ± chemotherapy in older patients with head and neck cancer. A sub-analysis of the REALKEY Study
2026
·
Matteo Carpani
, Luigi Lorini
, et al.
·
Radiotherapy and Oncology
The potential prognostic value of the head and neck advanced lung inflammation index (HN-ALI) for patients treated with immunotherapy.
2024
·
Daria Maria Filippini
, Francesca Carosi
, et al.
·
Journal of Clinical Oncology
PDF
Author response for "Second Primary Tumors in head and neck cancer patients: the importance of a “tailored” surveillance"
2020
·
F Bertolini
, L Trudu
, et al.
·
Publons reviews and discussion
953P Sarcopenia as predictive factor of response to nivolumab in recurrent-metastatic head and neck (RM-SCCHN) cancer patients
2020
·
F.M. Schipilliti
, A. Pecchi
, et al.
·
Annals of Oncology
PDF
Prognostic value of neutrophil-to-lymphocyte ratio (NLR) in metastatic castration-resistant prostate cancer (mCRPC) pts receiving a new agent (NA)- based third line treatment: Final results from a multicenter Italian study.
2017
·
Orazio Caffo
, Emilio Bria
, et al.
·
Journal of Clinical Oncology
Prognosis of Brca1 and Brca2-Related Breast Cancers: are There Differences?
2014
·
Z. Ballatore
, M. Pistelli
, et al.
·
Annals of Oncology
9320 Treatment with intravenous High Dose Interferon (HDI) is able to reduce levels of circulating regulatory T (Treg) cells in melanoma patients
2009
·
P. Ascierto
, G. Gentilcore
, et al.
·
European Journal of Cancer Supplements
Reduction of circulating regulatory T cell (Treg) by intravenous high-dose interferon (HDI) treatment in melanoma patients
2009
·
P. A. Ascierto
, M. Napolitano
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
18
Citation count:
252
H-index:
6
I10-index:
5
Year
Topic
Type